Unlock Exclusive Discounts & Flash Sales! Click Here to Join the Deals on Every Wednesday!
Estrogen receptor alpha (ERα) 1 gene (ESR1) mutations are frequently detected in ER+ metastatic breast cancer, and accumulating evidence suggests that these mutations confer endocrine resistance in patients with advanced breast cancer. However, their functional role is unclear, at least in part due to the lack of ESR1 mutation models.